The short version of Research chemical fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-09-15 and is reviewed periodically as new material appears.
Chemically, dihexa belongs to a broader group of angiotensin IV analogs. Researchers have modified the natural peptide to alter stability, binding, or distribution. Such changes can affect how the molecule behaves in experiments. The parent peptide angiotensin IV is involved in various physiological processes, but the modified analog is not identical to it. Public summaries sometimes blur the distinction between the natural fragment and the synthetic research compound. This distinction matters when interpreting study results.
Dihexa is a synthetic peptide that has been examined in laboratory and animal research. Its design is based on angiotensin IV, a naturally occurring peptide fragment produced in the body. The short name dihexa appears in scientific papers and online discussions, while the full chemical name describes a modified peptide chain. It is not a vitamin, mineral, or plant-derived compound. Suppliers typically present it as a research chemical rather than an approved medicine.
The full name often given is N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide. This name indicates a chain containing tyrosine, isoleucine, and a six-carbon amino acid derivative. Databases list a CAS Registry Number and a molecular formula for the compound. The peptide is small compared with proteins, and its structure allows it to be studied in cell cultures and animal models. Exact identity depends on the supplier's synthesis and purification process. Minor impurities can remain after synthesis.
Purity and identity are usually assessed with reverse-phase high-performance liquid chromatography (RP-HPLC) and mass spectrometry. RP-HPLC separates components by hydrophobicity and can estimate peptide purity. Mass spectrometry confirms molecular mass and helps detect truncations or modifications. Some laboratories also use amino acid analysis or nuclear magnetic resonance for structural verification. A certificate of analysis from a supplier may list these results, but independent verification is often recommended for critical work.
Regulatory status varies by country, and dihexa is not widely approved as a medicine. In many jurisdictions it is treated as a research chemical, which limits its legal sale, possession, and human use. Products marketed online may lack verified purity or identity, and labels can be inaccurate. Researchers typically source material from suppliers that provide analytical documentation and follow institutional safety rules. Open questions remain about long-term stability, metabolite formation, and human pharmacokinetics.
Dihexa is typically supplied as a lyophilized powder for laboratory research. Lyophilization removes water and improves stability during transport and storage. The solid is commonly stored at -20 °C or lower, desiccated, and protected from light. Repeated freeze-thaw cycles and exposure to moisture can degrade peptides, so aliquoting and sealed containers are standard practice in most laboratory settings. These handling measures apply to research-grade material and do not imply clinical suitability.
| Property | Value | Notes |
|---|---|---|
| Common name | Dihexa | Shorthand used in research literature and supplier catalogs. |
| CAS Registry Number | 1401708-83-5 | Identifier assigned to the synthetic peptide. |
| Molecular formula | C27H44N4O5 | Reported formula; verify with a certificate of analysis. |
| Appearance | White to off-white powder | Typical form for lyophilized research peptides. |
| Typical storage | −20 °C or below, desiccated | Common condition for peptide stability. |
Dihexa is a synthetic peptide with the chemical name N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide, and it is structurally related to angiotensin IV, a naturally occurring peptide fragment. Researchers developed it as a modified analog intended to alter stability and activity relative to the parent peptide. Its short sequence and fatty acid chain distinguish it from many endogenous peptides, and published studies often describe it under the abbreviation dihexa. The compound is classified as a laboratory compound rather than an approved therapeutic in most jurisdictions.
Early laboratory work focused on its effects on synaptic connectivity and neuronal signaling. In cell and animal models, dihexa has been reported to promote the formation of new synapses, a process called synaptogenesis. These findings have generated interest in cognitive research, but the evidence base remains mostly preclinical. Human clinical trials with clear safety and efficacy endpoints are limited or absent in the public literature. Whether these effects translate to humans is an open question.
Dissolution depends on the peptide’s salt form, purity, and the chosen solvent. Dimethyl sulfoxide is commonly used to prepare concentrated stock solutions, while aqueous buffers may show limited solubility. Sonication or gentle warming can sometimes aid dissolution, but excessive heat may promote degradation. Once in solution, the material is generally kept cold and protected from light. Researchers should verify solubility for each lot rather than assuming uniform behavior across suppliers.
Quality control usually combines reverse-phase high-performance liquid chromatography with mass spectrometry. Chromatography estimates purity and detects related impurities, while mass spectrometry supports molecular identity. Nuclear magnetic resonance can provide additional structural confirmation when needed. Stability data for dihexa are limited, and degradation pathways may depend on pH, temperature, and moisture. Open questions include long-term stability in different formulations and the effect of repeated freeze-thaw cycles on measured purity. Such tests help confirm that a batch matches its label before use.
In laboratory settings, dihexa is typically handled as a lyophilized peptide powder. Appropriate personal protective equipment and a ventilated workspace are standard practices for weighing and transferring research chemicals. Because the compound lacks regulatory approval for clinical use, it should not be given to people. Institutional safety rules and local regulations govern its acquisition, storage, and disposal. Suppliers often provide a certificate of analysis that lists purity, identity, and batch-specific handling notes.
Human safety data are sparse. No widely accepted dosing regimen, long-term safety profile, or clinical efficacy endpoint has been established. Published animal results can suggest directions for further study, but species differences and study design limit direct translation. Open questions include bioavailability, blood-brain barrier penetration, metabolism, and whether observed effects arise from a single target or multiple pathways. Replication across independent laboratories remains an important benchmark for evaluating the strength of preclinical claims.
Most published reports on dihexa come from cell cultures and animal models. Studies have examined markers of synapse formation, dendritic spine density, and performance on learning tasks in rodents. Proposed mechanisms center on hepatocyte growth factor and its c-Met receptor, with additional attention to angiotensin IV-related pathways. These findings are experimental and have not been confirmed as clinical benefits in humans. The literature often uses different tasks and endpoints, which complicates direct comparison across studies.
Regulatory status differs by country, but dihexa is generally not approved as a therapeutic product. It is often sold as a research chemical, which means purity, labeling, and handling fall outside pharmaceutical drug standards. Some jurisdictions restrict the sale of peptides intended for human consumption. Researchers and suppliers may therefore face different legal requirements depending on location. Import rules and customs enforcement can also affect how such compounds move across borders.
Identity checks for dihexa usually rely on mass spectrometry and chromatographic purity analysis. A lyophilized powder is the common supplied form, and it may appear as a white to off-white solid. Aqueous solubility is limited, so laboratory work often uses an organic solvent such as dimethyl sulfoxide to prepare stock solutions. Because the peptide is not a standard pharmaceutical product, exact specifications can vary between suppliers. Certificates of analysis may accompany a batch, but they are not equivalent to regulatory approval.
Dihexa is a synthetic peptide whose structure is modeled on angiotensin IV. Its chemical name often appears as N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide, though vendor and publication naming can differ. The molecule combines a short amino acid sequence with a hexanoic acid group and an amide terminus. It is classed as a small research peptide rather than a conventional drug. Databases may list it under several synonyms, so matching names are important when comparing sources.
He caucused with Democrats in the House while refusing to join the party, and continues to caucus with Democrats in the Senate. Some conservative southern House Democrats initially barred him from the caucus as they believed that allowing a self-described socialist to join would harm their electoral prospects. He soon came to work constructively with Democrats, voting with the party over 90% of the time during his tenure in Congress. Starting with his 2016 presidential campaign, Sanders's announcements suggested that not only was he running as a Democrat, but that he would run as a Democrat in future elections. When challenged by Clinton about his party commitment, he said, "Of course I am a Democrat and running for the Democratic nomination." Since he remained a senator elected as an independent, his US Senate website and press materials continued to refer to him as an independent during the campaign and upon his return to the Senate. In October 2017, Sanders said he would run for reelection as an independent in 2018 despite pressure to run as a Democrat. His party status became ambiguous again in March 2019 when he signed a formal "loyalty pledge" to the Democratic Party stating that he was a member of the party and would serve as a Democrat if elected president. He signed the pledge the day after he signed paperwork to run as an independent for reelection to the Senate in 2024.
Ammonium sulfate (American English and international scientific usage; ammonium sulphate in British English); [NH4]2SO4, is an inorganic salt with a number of commercial uses. The most common use is as a soil fertilizer. It contains 21% nitrogen and 24% sulfur.
Formic acid is a colorless liquid having a pungent, penetrating odor at room temperature, comparable to the related acetic acid. Formic acid is about 10 times stronger of an acid than acetic acid; its (logarithmic) dissociation constant (pKa) is 3.745, compared to the pKa of 4.756 for acetic acid. It is miscible with water and most polar organic solvents, and is somewhat soluble in hydrocarbons. In hydrocarbons and in the vapor phase, it consists of hydrogen-bonded dimers rather than individual molecules. Owing to its tendency to hydrogen-bond, gaseous formic acid does not obey the ideal gas law. Solid formic acid, which can exist in either of two polymorphs, consists of an effectively endless network of hydrogen-bonded formic acid molecules. Formic acid forms a high-boiling azeotrope with water (107.3 °C; 77.5% formic acid). Liquid formic acid tends to supercool.
== External links == Proprotein+Convertase+1 at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Overview of all the structural information available in the PDB for UniProt: P63239 (Mouse Neuroendocrine convertase 1) at the PDBe-KB.
Sources: en.wikipedia.org
== Structure == GFP has a beta barrel structure consisting of eleven β-strands with a pleated sheet arrangement, with an alpha helix containing the covalently bonded chromophore 4-(p-hydroxybenzylidene)imidazolidin-5-one (HBI) running through the center. Five shorter alpha helices form caps on the ends of the structure. The beta barrel structure is a nearly perfect cylinder, 42Å long and 24Å in diameter (some studies have reported a diameter of 30Å), creating what is referred to as a "β-can" formation, which is unique to the GFP-like family. HBI, the spontaneously modified form of the tripeptide Ser65–Tyr66–Gly67, is nonfluorescent in the absence of the properly folded GFP scaffold and exists mainly in the un-ionized phenol form in wtGFP. Inward-facing sidechains of the barrel induce specific cyclization reactions in Ser65–Tyr66–Gly67 that induce ionization of HBI to the phenolate form and chromophore formation. This process of post-translational modification is referred to as maturation. The hydrogen-bonding network and electron-stacking interactions with these sidechains influence the color, intensity and photostability of GFP and its numerous derivatives. The tightly packed nature of the barrel excludes solvent molecules, protecting the chromophore fluorescence from quenching by water. In addition to the auto-cyclization of the Ser65-Tyr66-Gly67, a 1,2-dehydrogenation reaction occurs at the Tyr66 residue. Besides the three residues that form the chromophore, residues such as Gln94, Arg96, His148, Thr203, and Glu222 all act as stabilizers.
The maximum temperature is limited to that at which the stationary phase is stable. C18 bonded phases which are common in HPLC seem to be stable at temperatures up to 200 °C, far above that of pure silica, and polymeric styrene–divinylbenzene phases offer similar temperature stability.
==== 2012 Jalisco massacres ==== The dismembered remains of 18 bodies were found inside a Toyota Sienna and Ford EcoSport near the U.S. retiree communities in Chapala, Jalisco, just south of the city of Guadalajara. Eighteen heads were found along the dismembered bodies; some had been frozen, others were covered in lime, and the rest were found in an advanced state of decomposition. An anonymous call alerted the police to the abandoned vehicles, which were found by the side of a highway early in the morning on 9 May 2012. They were consequently towed to government offices to unload the bodies. The authorities confirmed that a message was left behind by the killers, presumably from Los Zetas and the Milenio Cartel. The attorney general of the state of Jalisco, Tomás Coronado Olmos, stated that this massacre was a revenge attack for the 23 killed in the 2012 Nuevo Laredo massacres. In addition, 25 people were rescued after being kidnapped in Tala, Jalisco on 8 May 2012; the killers had plans to kill and "throw" them for public display. Another 10 people managed to escape their capture by members of Los Zetas that same day, and alerted the local media of the situation. Upon the arrest of the four alleged killers, one of the cartel members confessed that they had plans to "repeat" what had happened in the 2011 Guadalajara massacre, where 26 bodies were dumped in a major avenue for public display. According to Proceso magazine, Los Zetas were planning to kill 50 people on 9 May 2012, a day before Mother's Day.
Sources: en.wikipedia.org
and he was wearing camouflage, a hunting vest and had an AR-15 strapped to his back" and that God supported Trump's plan to arm teachers. Following the death of Billy Graham on February 21, 2018, Bakker attended Graham's funeral and paid his respects, stating that Graham was the greatest preacher since Jesus, and also remarking that Graham had visited him in prison. On the Stand in the Gap Today radio program, Pennsylvania Pastors Network president Sam Rohrer criticized Bakker's civil-war prediction. Christian Today criticized Bakker's show for preying on "the most vulnerable kinds of people" and claimed that it had "no place on our TV screens."
Roosevelt quickly understood the implications, stating, "Alex, what you are after is to see that the Nazis don't blow us up." Roosevelt ordered the formation of the Advisory Committee on Uranium. In February 1940, encouraged by Fermi and John R. Dunning, Alfred O. C. Nier was able to separate U-235 and U-238 from uranium tetrachloride in a glass mass spectrometer. Subsequently, Dunning, bombarding the U-235 sample with neutrons generated by the Columbia University cyclotron, confirmed "U-235 was responsible for the slow neutron fission of uranium." At the University of Birmingham, Frisch teamed up with Rudolf Peierls, who had been working on a critical mass formula. assuming isotope separation was possible, they considered 235U, which had a cross section not yet determined, but which was assumed to be much larger than that of natural uranium. They calculated only a pound or two in a volume less than a golf ball, would result in a chain reaction faster than vaporization, and the resultant explosion would generate temperature greater than the interior of the sun, and pressures greater than the center of the earth. Additionally, the costs of isotope separation "would be insignificant compared to the cost of the war." By March 1940, encouraged by Mark Oliphant, they wrote the Frisch–Peierls memorandum in two parts, "On the construction of a 'super-bomb; based on a nuclear chain reaction in uranium," and "Memorandum on the properties of a radioactive 'super-bomb.' ". On 10 April 1940, the first meeting of the MAUD Committee was held.
AT-121 is an experimental analgesic. It was designed to be bifunctional, acting as an agonist at both the μ-opioid receptor and the nociceptin receptor. The interaction with the nociceptin receptor is expected to block the abuse and dependence-related side effects that are typical of opioids. A study in nonhuman primates found that AT-121 has morphine-like analgesic effects, but suppressed the addictive effects.
In some reactions, protons and hydroxide may directly act as acid and base in term of specific acid and specific base catalysis. But more often groups in substrate and active site act as Brønsted–Lowry acid and base. This is called general acid and general base theory. The easiest way to distinguish between them is to check whether the reaction rate is determined by the concentrations of the general acid and base. If the answer is yes then the reaction is the general type. Since most enzymes have an optimum pH of 6 to 7, the amino acids in the side chain usually have a pKa of 4~10. Candidate include aspartate, glutamate, histidine, cysteine. These acids and bases can stabilise the nucleophile or electrophile formed during the catalysis by providing positive and negative charges.
Sources: en.wikipedia.org
Dihexa is a synthetic peptide modeled on angiotensin IV. It is used in laboratory and animal research, not as an approved medicine. Human effects remain poorly characterized.
It is produced by chemical synthesis, not extracted from plants or animals. Its design is based on a naturally occurring peptide fragment. Suppliers sell it as a research chemical.
No, dihexa is a modified analog of angiotensin IV. The two share a structural relationship but differ in chemical details. Research on one does not automatically apply to the other.
The lyophilized powder is generally stored at -20 °C or lower, desiccated, and protected from light. Solutions are often aliquoted to avoid repeated freeze-thaw cycles. Specific stability data may vary by formulation and purity.